Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02924766
Title A Safety and Pharmacokinetics Study of Niraparib Plus Apalutamide in Men With Metastatic Castration-Resistant Prostate Cancer (BEDIVERE)
Recruitment Completed
Gender male
Phase Phase I
Variant Requirements No
Sponsors Janssen Research & Development, LLC
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | CAN

Facility Status City State Zip Country Details
West Hollywood California United States Details
Louisville Kentucky United States Details
Portland Oregon United States Details
Myrtle Beach South Carolina United States Details
Vancouver British Columbia Canada Details
Montreal Quebec Canada Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field